Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis

Multiple Sclerosis

Volumn 6, Issue 1, 2000, Pages 3-13

  Zhang, G X ^a   Baker, C M ^a   Kolson, D L ^a   Rostami, A M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokine; EAE; Inflammation; MS

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; MYELIN BASIC PROTEIN; RANTES;

ALLERGIC ENCEPHALOMYELITIS; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE MIGRATION; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; VACCINATION;

EID: 0034021267     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800678827446     Document Type: Review

References (126)

1. Van Damme J. Interleukin-8 and related chemotactic cytokines: Thomson A (ed) The cytokine handbook. London: Academic Press; 1994, 185-208.
2. Clark-Lewis I et al. (1995) Structure-activity relationships of chemokines. J Leuk Biol 57: 703-711.
3. Garcia-Zepeda EA et al. (1996) Human monocytes chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 157: 5613-5626.
4. Luster AD. (1998) Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445.
5. Bazan JF et al. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644.
6. Mizoue LS, Bazan JF, Johnson EC, Handel TM. (1999) Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38: 1402-1414.
7. Pan Y et al. (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387: 611-617.
8. Khan O et al. (1996) Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 46: 1639-1643.
9. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. (1991) Properties of the novel proinflammatory supergene intercrine cytokine family. Annu Rev Immunol 9: 617-648.
10. Miller MD, Krangel MS. (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12: 17-42.
11. Proost P, Wuyts A, Damme JV. (1996) The role of chemokines in inflammation. Int J Clin Lab Res 26: 211-223.
12. Baggiolini M. (1998) Chemokines and leukocyte traffic. Nature 392: 565-568.
13. Zlotnik A, Morales J, Hedrick JA. (1999) Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19: 1-47.
14. Karpus WJ et al. (1995) An important role for the chemokine macrophage inflammatory protein-1-a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155: 5003-5010.
15. Gunn MD et al. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189: 451-460.
16. Proudfoot AEI, Wells TNC, Clapham PR. (1999) Chemokine receptors - Future targets for HIV? Biochem Pharmacol 57: 451-463.
17. Sallusto F, Lanzavecchia A, Mackay CR. (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574.
18. Annunziato F et al. (1999) Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol 65: 691-699.
19. Lukacs NW et al. (1988) Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1a by inflammatory granuloma fibroblasts. Am J Pathol 144: 711-718.
20. Hedrick JA and Zlotnik A. (1996) Chemokines and lymphocyte biology. Curr Opin Immunol 8: 343-347.
21. Lavi E et al. (1998) Chemokine receptors in the human brain and their relationship to HIV infection. J Neurovirol 4: 301-311.
22. Hesselgesser J et al. (1997) Functional chemokine receptor expression in human neuronal cells: evidence for a CD4 independent association between HIV-1 gp120 and the viral coreceptor CXCR4. Curr Biol 7: 112-121.
23. Hesselgesser J et al (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4. Curr Biol 8: 595-598.
24. Hesselgesser J, Horuk R. (1999) Chemokines and chemokine receptor expression in the central nervous system. J Neurovirol 5: 13-26.
25. Sorensen T et al. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103: 807-815.
26. Bleul CC et al. (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94: 1925-1930.
27. Wu LJ et al. (1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185: 1681-1691.
28. Sica A et al. (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185: 969-974.
29. He J et al. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645-649.
30. Berger EA. (1997) HIV entry and tropism: the chemokine receptor connection. AIDS 11: S3-S16.
31. Clapham PR, Weiss RA. (1997) Spoilt for choice of co-receptors. Nature 388: 230-231.
32. D'Souza MP, Harden VA. (1996) Chemokines and HIV-1 second receptors. Nature Med 2: 1293-1300.
33. Spanaus KS et al. (1997) C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol 158: 1956-1964.
34. Schmidtmayerova H et al. (1996) Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 93: 700-704.
35. Rollins B, Walz A, Baggiolini M. (1991) Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112-1116.
36. Randolph GJ, Furie MB. (1995) A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol 155: 3610-3618.
37. Yi J et al. (1997) CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1. J Virol 72: 772-777.
38. Heesen M et al. (1996) Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J Neurosci Res 45: 382-391.
39. Heesen ML et al. (1997) Alternate splicing of mouse fusin/CXC chemokine receptor-4. J Immunol 158: 3561-3564.
40. Tanabe S et al. (1997) Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159: 905-911.
41. Westmoreland SV et al. (1998) Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am J Pathol 152: 659-665.
42. Meucci O et al. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500-14505.
43. Horuk R et al. (1996) The duffy antigen receptor for chemokines structural analysis and expression in the brain. J Leukocyte Biol 59: 29-38.
44. Horuk R et al. (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890.
45. Tani M et al. (1996) Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest 98: 529-539.
46. Eng LF, Ghirnikar RS, Lee YL. (1995) Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem Res 21: 511-525.
47. Constantinescu CS et al. (1998) Pathogenesis of Neuroimmunologic Diseases. Immunol Res 171: 217-227.
48. Arnason BG. (1983) Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol Clin 1: 765-782.
49. Wekerle H. (1991) Immunopathogenesis of multiple sclerosis. Acta Neurol 13: 197-204.
50. Traugott U, McFarlin DE, Raine CS. (1986) Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell Immunol 99: 395-410.
51. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH. (1997) A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 186: 1233-1240.
52. Navikas V, Link H. (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45: 322-333.
53. Lublin FD. Experimental models of autoimmune demyelination; In: Cook SD (ed): Handbook of multiple sclerosis. 2nd ed. New York, Marcel Dekker, 1996, pp. 119-143.
54. Unanue ER, Allen PM. (1987) The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236: 551-557.
55. Wolpe SD et al. (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167: 570-581.
56. Bacon KB, Premack BA, Gardner P, Schall TJ. (1995) Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
57. Karpus WJ, Kennedy KJ. (1997) MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leuk Biol 62: 681-687.
58. Taub DD et al. (1996) Chemokines and T lymphocyte activation. I. Chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156: 2095-2103.
59. Duijevtijn AM. Schreiber AB, Butcher EC. (1986) Interferon-γ regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc Natl Acad Sci USA 83: 9114-9118.
60. Davatelis G et al. (1988) Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J Exp Med 167: 1939-1944.
61. Farber JM. (1997) MIG and IP-10: CXC chemokines that target lymphocytes. J Leuk Biol 61: 246-257.
62. McRae BL et al. (1992) Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 38: 229-240.
63. Bernard CC et al. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75: 77-88.
64. Kojima K et al. (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med 180: 817-829.
65. Tuohy VK et al. (1992) Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J Neuroimmunol 39: 67-74.
66. Ransohoff R. (1997) Chemokines in neurologic disease models: correlation between chemokine expression patterns and inflammatory pathology. J Leuk Biol 62: 645-652.
67. Godiska R, Chantry D, Dietsch GN, Gray PW. (1995) Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58: 167-176.
68. Glabinski AR et al. (1999) Chemokine expression in GKO mice (lacking interferon-gamma) with experiental autoimmune encephalomyelitis. Neurovirol 5: 95-101.
69. Miyagishi R et al. (1996) Identification of cell types producing RANTES, MIP-1a and MIP-1b in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 77: 17-26.
70. Kuchroo VK et al. (1993) Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 151: 4371-4382.
71. Glabinski AR et al. (1997) Synchronous synthesis of a- and b- chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Path 150: 617-630.
72. Karpus WI et al. (1997) Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158: 4129-4136.
73. Lukacs NW et al. (1997) C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol 150: 1861-1868.
74. Ransohoff RM et al. (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7: 592-600.
75. Tani M et al. (1996) In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. Am J Pathol 148: 889-896.
76. Karpus WJ, Lukacs NW. (1996) The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. Ann NY Acad Sci 778: 133-144.
77. Karpus WJ, Kennedy KJ, Kunkel SL, Lukacs NW. (1998) Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med 187: 733-741.
78. Vanguri P, Cho SY, Chi CM. (1996) Role of muIP-10 in interferon-gamma induction of Ia in rat astrocytes. Mol Immunol 33: 1079-1087.
79. Rossi DL et al. (1998) Cloning and characterization of a new type of mouse chemokine. Genomics 47: 163-170.
80. Raport CJ et al. (1995) The orphan G-protein-coupled receptor-encoding gene V28 is closely related to genes for chemokine receptors and is expressed in lymphoid and neural tissues. Gene 163: 295-299.
81. Nishiyori A et al. (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429: 167-172.
82. Asensio VC et al. (1999) C10 is a novel chemokine expressed in experimental inflammatory demyelinating disorders that promotes recruitment of macrophages to the central nervous system. Am J Pathol 154: 1181-1191.
83. McKhann GM. (1990) Guillain-Barré syndrome: clinical and therapeutic observations. Ann Neurol 27: S13-S16.
84. Merrill JE. (1992) Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 12: 167-170.
85. McFarland HF. (1996) Complexities in the treatment of autoimmune disease. Science 274: 2037-2038.
86. Whitham RH et al. (1991) Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol 146: 101-107.
87. van Noort JM et al. (1995) The small heat-shock protein, a B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375: 798-801.
88. Kerlero de Rosbo N et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27: 3059-3069.
89. Hafler DA et al. (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 312: 1405-1411.
90. Hohlfeld R, Londei M, Massacesi L, Salvetti M. (1995) T-cell autoimmunity in multiple sclerosis. Immunol Today 16: 259-261.
91. Voskuhl RR et al. (1993) T helper 1(Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15: 137-143.
92. Van Der Voorn P et al. (1999) Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol 154: 45-51.
93. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. (1998) Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84: 238-249.
94. McManus C et al. (1998) MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86: 20-29.
95. Fiten P et al. (1999) Microsatellite polymorphisms in the gene promoter of MCP-3 alleles and multiple sclerosis development. J Neuroimmunol 95: 195-201.
96. Luo Y et al. (1998) The CXC-chemokine, H174: expression in the central nervous system. J Neurovirol 4: 575-585.
97. Biddison WE et al. (1997) Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: potential roles in inflammation. J Immunol 158: 3046-3053.
98. Barnes DA et al. (1996) Induction of RANTES expression by astrocytes and astrocytoma cell lines. J Neuroimmunol 71: 207-214.
99. Miyagishi R, Kikuchi S, Fukazawa T, Tashiro K. (1995) Macrophage inflammatory protein-1alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J Neurol Sci 129: 223-227.
100. Muller-Ladner U et al. (1996) Enhanced expression of chemtactic receptors in multiple sclerosis lesions. J Neurol Sci 144: 135-141.
101. Balashov KE et al. (1999) CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Nat Acad Sci USA 96: 6873-6878.
102. Bennetts BH et al. (1997) The CCR5 deletion mutation fails to protect against multiple sclerosis. Human Immunol 58: 52-59.
103. Liu R et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
104. Hesselgesser J et al. (1998) Identifcation and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. Journal of Biological Chemistry 273: 15687-15692.
105. Tani M, Ransohoff RM. (1994) Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathol 4: 135-143.
106. Masuyama J, Minato N, Kano S. (1986) Mechanisms of lymphocyte adhesion of human vascular endothelial cells in culture: T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma Interferon. J Clin Invest 77: 1596-1605.
107. Tanaka Y et al. (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361: 79-82.
108. Gerszten RE et al. (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723.
109. Tanaka Y et al. (1998) Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis. Arthr Rheum 41: 1365-1377.
110. Shaw LM, Mercurio AM. (1989) Interferon-γ and lipopolysaccharide promote macrophage adherence to basement membrane glycoproteins. J Exp Med 169: 303-308.
111. Cannella B, Cross AH, Raine CS. (1990) Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 172: 1521-1524.
112. Yednock TA et al. (1993) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63-66.
113. Lukacs NW et al. (1994) Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. Blood 83: 1174-1178.
114. Archelos JJ, Previtali SC, Hartung HP. (1999) The role of integrins in immune-mediated diseases of the nervous system. Trend Neurosci 22: 30-38.
115. Pinkstaff JK, Detterich J, Lynch G, Gall C. (1999) Integrin subunit gene expression is regionally differentiated in adult brain. J Neurosci 19: 1541-1556.
116. Opdenakker G, Van Damme J. (1994) Cytokine-regulated proteases in autoimmune diseases. Immunol Today 15: 103-107.
117. Proost P, Van Damme J, Opdonakker G. (1993) Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem Biophys Res Commun 192: 1175-1181.
118. Gijbels K et al. (1993) Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 36: 432-440.
119. Dubois B, Opdonakker G, Carton H. (1999) Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neurol Belg 99: 53-56.
120. Youssef S et al. (1998) Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J Immunol 161: 3870-3879.
121. Stuve O et al. (1997) Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J Neuroimmunol 80: 38-46.
122. Foxman EF, Campbell JJ, Butcher EC. (1997) Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139: 1349-1360.
123. Strieter RM et al. (1996) "The good, the bad, and the ugly". The role of chemokines in models of human disease. J Immunol 156: 3583-3586.
124. Utans-Schneitz U et al. (1998) A novel rat CC chemokine identified by targeted differential display, is upregulated in brain inflammation. J Neuroimmunol 92: 179-190.
125. Reiseter BS, Miller GT, Happ MP, Kasaian MT. (1998) Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid. J Neuroimmunol 91: 156-170.
126. Smeltz RB, Wolf NA, Swanborg RH. (1999) Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol 163: 1390-1397.